ACE2, the first known human homologue of angiotensin-converting enzyme (ACE), was
identified from 5′ sequencing of a human heart failure ventricle cDNA library. ACE2 has an …

Human angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a zinc
metalloprotease whose closest homolog is angiotensin I-converting enzyme. To begin to elucidate …

Bortezomib [N-(2,3-pyrazine)carbonyl-l-phenylalanine-l-leucine boronic acid] is a potent first-in-class
dipeptidyl boronic acid proteasome inhibitor that was approved in May 2003 in the …

Di-docosahexaenoyl (C22:6)-bis(monoacylglycerol) phosphate (BMP) was identified as a
promising phospholipidosis (PL) biomarker in rats treated with either amiodarone, gentamicin, …

ACE2, the first known human homologue of angiotensin-converting enzyme (ACE), was
identified from 5 sequencing of a human heart failure ventricle cDNA library. ACE2 has an …

The high resolution of capillary zone electrophoresis/mass spectrometry (CZE/MS) offers a
promising technique to characterize biomolecules in pharmaceutical and biotechnology …

Tallahassee, FL; 2Mosaique Diagnostics and Therapeutics, Hannover, Germany WOCpm
04:20 The Top-down Characterization of Nucleic Page 1 52nd ASMS Conference on Mass …

Immune evasion is a hallmark of cancer and a central mechanism underlying acquired
resistance to immune therapy. In allogeneic hematopoietic cell transplantation (alloHCT), late …

Recent studies have highlighted the critical role of CD103 + /CD141 + dendritic cells (DCs) in
antitumor immunity. CDX-301 is a soluble, recombinant human FLT3 ligand (Flt3L). Flt3L is …

Limitations of immunotherapy include poorly functioning events early in the immune
response cycle, such as efficient antigen presentation and T cell priming. CD40 signaling in …